1 p.m. Eastern on Oct. 16
NGS applications: Assessing clonality and diversity
Speakers:
- Rebecca Ramesh, M.D., Hospital of the University of Pennsylvania
- Jeremiah X. Karrs, D.O., Dartmouth Hitchcock/Geisel School of Medicine
4 p.m. Eastern on Oct. 21, 2025
Introduction to molecular biomarkers: Evidence and guidelines
Speakers:
- Eric Vail, M.D., Cedars–Sinai Medical Center
- Paul M. Waring, Ph.D., Translational Pathology Consulting Services
This webinar is part of the Current Concepts in Molecular Testing for HR+/HER2- Metastatic Breast Cancer series.
4 p.m. Eastern on Oct. 27, 2025
Molecular testing strategies and evaluation of assay performance
Speakers:
- Katherine B. Geiersbach, M.D., Mayo Clinic
- Shuko Harada, M.D., University of Alabama at Birmingham
This webinar is part of the Current Concepts in Molecular Testing for HR+/HER2- Metastatic Breast Cancer series.
2 p.m. Eastern on Oct. 30, 2025
Applying molecular testing in practice with case discussions and expert panel
Speaker: Karthik Giridhar, M.D., Mayo Clinic
This webinar is part of the Current Concepts in Molecular Testing for HR+/HER2- Metastatic Breast Cancer series.
November 11–15, 2025
AMP 2025 Annual Meeting & Expo
Boston, Massachusetts, USA
2:30 p.m. on Dec. 18, 2025
Developing Consensus for a More Provider-Friendly Next-Generation Sequencing Molecular Biomarker Report
Speaker: Jane Gibson, Ph.D., University of Central Florida College of Medicine
Moderator: Anthony Snow, M.D., University of Iowa Hospitals and Clinics
June 15-17, 2026
AMP Europe 2026 Meeting
Tallinn, Estonia
November 10–14, 2026
AMP 2026 Annual Meeting & Expo
Seattle Convention Center
Seattle, Washington
AMP 2027 Annual Meeting & Expo
Baltimore, Maryland
AMP 2028 Annual Meeting & Expo
Nov. 7–11, 2025
Honolulu, Hawaii